Stefán Jökull Sveinsson
Keine laufenden Positionen mehr
Profil
Stefán Jökull Sveinsson currently works at Nepsone ehf, as Chief Executive Officer and Akthelia ehf, as Director.
Mr. Sveinsson also formerly worked at Actavis Group hf, as Chief Executive Officer-Research & Development from 2002 to 2010, Oculis SA, as Director, the University of Iceland, as Professor from 1991 to 1993, and Actavis, Inc., as Executive Vice President-Research & Development from 2002 to 2013.
Mr. Sveinsson received his graduate degree from Dalhousie University.
Aktive Positionen von Stefán Jökull Sveinsson
Unternehmen | Position | Beginn |
---|---|---|
Akthelia ehf
Akthelia ehf Pharmaceuticals: MajorHealth Technology Akthelia ehf manufactures pharmaceutical products. It focuses on the discovery and development of novel antimicrobial therapeutics, which enhance the body‘s innate microbial defences. The company was founded by Eirikur Steingrimsson and Eirikur Steingrímsson and is headquartered in Reykjavik, Iceland. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Stefán Jökull Sveinsson
Unternehmen | Position | Ende |
---|---|---|
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Direktor/Vorstandsmitglied | 04.01.2019 |
Actavis, Inc. /Old/
Actavis, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Actavis, Inc. is engaged in developing, manufacturing and sale of generic pharmaceuticals. They provide a variety of medicines in different formulations including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi-solids. The company is located in Morristown, NJ. | Technik-/Wissenschafts-/F&E-Leiter | 24.01.2013 |
University of Iceland | Corporate Officer/Principal | 01.01.1993 |
Actavis Group hf
Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Stefán Jökull Sveinsson
Dalhousie University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 4 |
---|---|
Actavis Group hf
Actavis Group hf Pharmaceuticals: MajorHealth Technology Actavis Group hf develops, manufactures and sells generic pharmaceuticals. The company was founded in 1957 and is headquartered in Hafnarfjörður, Iceland. | Health Technology |
Actavis, Inc. /Old/
Actavis, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Actavis, Inc. is engaged in developing, manufacturing and sale of generic pharmaceuticals. They provide a variety of medicines in different formulations including tablets, capsules, injectables, suppositories, sprays, steriles, powders, oral liquids and semi-solids. The company is located in Morristown, NJ. | Health Technology |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Commercial Services |
Akthelia ehf
Akthelia ehf Pharmaceuticals: MajorHealth Technology Akthelia ehf manufactures pharmaceutical products. It focuses on the discovery and development of novel antimicrobial therapeutics, which enhance the body‘s innate microbial defences. The company was founded by Eirikur Steingrimsson and Eirikur Steingrímsson and is headquartered in Reykjavik, Iceland. | Health Technology |